Brief: INOVIO Announces Pricing Of $20.0 Million Public Offering
30/07/2026 01:55
BRIEF-INOVIO Announces Pricing Of $20.0 Million Public Offering July 29 (Reuters) - Inovio Pharmaceuticals Inc INO.O:
INOVIO ANNOUNCES PRICING OF $20.0 MILLION PUBLIC OFFERING
INOVIO PHARMACEUTICALS - PRICES PUBLIC OFFERING OF 21,052,632 SHARES AND WARRANTS AT $0.95 PER SHARE
Source text: ID:nPn1tZNW2a
Further company coverage: INO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inovio Pharmaceuticals
See all newsBrief: Inovio Announces Favorable Judgment In Litigation With Vgxi, Inc. And Geneone Life Science
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Inovio Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Inovio Q2 net loss narrows on warrant gain, lower costs
Brief: Inovio Pharmaceuticals Q2 Operating Expenses USD 18.6 Million